HomeDAWN • NASDAQ
add
Day One Biopharmaceuticals Inc
Previous close
$9.41
Day range
$9.37 - $9.72
Year range
$5.64 - $14.46
Market cap
974.39M USD
Avg Volume
2.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 39.80M | -57.56% |
Operating expense | 59.57M | -4.75% |
Net income | -19.73M | -153.26% |
Net profit margin | -49.57 | -225.49% |
Earnings per share | -0.19 | -150.00% |
EBITDA | -23.37M | -177.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 451.58M | -19.13% |
Total assets | 513.78M | -14.49% |
Total liabilities | 62.91M | 38.74% |
Total equity | 450.87M | — |
Shares outstanding | 102.68M | — |
Price to book | 2.14 | — |
Return on assets | -11.74% | — |
Return on capital | -13.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.73M | -153.26% |
Cash from operations | -5.80M | -111.44% |
Cash from investing | 13.46M | 119.88% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 7.66M | -95.82% |
Free cash flow | 3.51M | 104.38% |
About
Founded
2018
Headquarters
Website
Employees
184
